Bioactivity:

FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer ac

CAS nr:

1255143-82-8

Purity:

98%

Molecular Weight:

822,6

SMILES:

CC1=CC=C(C(C)C)C=C1>>CN(C)C2=CC=C([N]3=NC4=CC=CC=[N]4[Os+]3I)C=C2.F[P-](F)(F)(F)(F)F

Formula:

C23H28F6IN4OsP

Pathway:

Target: